Plasma norepinephrine and mortality.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. I-9, doi. 10.1002/clc.4960181304
- By:
- Publication type:
- Article
Works matching IS 01609289 AND DT 1995 AND VI 18 AND IP S1
Results: 7
1
2
Sympathetic dysregulation in heart failure: Mechanisms and therapy.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. I-3, doi. 10.1002/clc.4960181303
- By:
- Publication type:
- Article
3
Clinical efficacy of ibopamine in patients with chronic heart failure.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. I-22, doi. 10.1002/clc.4960181307
- By:
- Publication type:
- Article
4
Introduction.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. I-1, doi. 10.1002/clc.4960181302
- By:
- Publication type:
- Article
5
Neurohormonal and hemodynamic effects of ibopamine.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. I-17, doi. 10.1002/clc.4960181306
- By:
- Publication type:
- Article
6
Masthead.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. fmi, doi. 10.1002/clc.4960181301
- Publication type:
- Article
7
Receptor systems involved in norepinephrine release in heart failure: Focus on dopaminergic systems.
- Published in:
- Clinical Cardiology, 1995, v. 18, n. S1, p. I-13, doi. 10.1002/clc.4960181305
- By:
- Publication type:
- Article